The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.
المخرجات
Research outputs
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
Improving energy efficiency is crucial for smart factories that want to meet sustainability goals and operational excellence. This study introduces a novel decision-making framework to optimize energy efficiency in smart manufacturing environments, integrating Intuitionistic Fuzzy Sets (IFS) with Multi-Criteria Decision-Making (MCDM) techniques. The proposed approach addresses key challenges, including reducing carbon footprints, managing operating costs, and adhering to stringent environmental standards. Eight essential criteria are identified, such as the use of renewable energy, the efficiency of production, and the health and safety of workers, to evaluate energy performance. Using the entropy method for criterion weighting and the CRADIS technique for alternative ranking, we prioritize a range of energy-efficient solutions. The novelty of our approach lies in its comprehensive assessment of complex real-world energy management scenarios within smart factories, offering a robust and adaptable decision-support tool. Our empirical results, validated through sensitivity analysis, show that alternative 5 delivers the most significant improvement in energy efficiency. This study provides valuable information for industry practitioners seeking to transition to more sustainable production methods and supports the broader sustainability agenda.
intuitionistic fuzzy setsmulti-criteria decision makingsustainable energy managementsmart factory
Bacterial biofilms pose a substantial challenge in healthcare and industrial and environmental settings because of their resilience and antibiotic resistance. Biofilm formation is a complex process involving microbial communities encased in an extracellular matrix that contributes to increased resistance and persistent infections. This review explores the emerging roles of bacteriophages and their derived enzymes as promising alternatives or adjunct therapies to combat bacterial biofilms. Bacteriophages, viruses that infect bacteria, exhibit marked specificity and diverse mechanisms for targeting and lysing bacterial cells within biofilms. Enzymes, including endolysins and depolymerases, have demonstrated efficacy in disrupting biofilm matrices. Moreover, the potential synergy between bacteriophages and antibiotics enhances their antimicrobial activity, providing a multifaceted approach for combating biofilm-associated infections. This review critically evaluates the current research, highlighting the successes and limitations of bacteriophage-based strategies in biofilm control, and underscores the potential of these alternatives in shaping future therapeutic interventions against biofilm-related bacterial infections.
Background: Migraine, a complex neurological condition, poses significant challenges for both sufferers and healthcare providers. While prescription medications play a vital role in managing migraine attacks, the quest for natural, non-pharmacological alternatives has garnered increasing interest. This review explores the efficacy and safety of natural supplements as treatments for migraine relief, comparing them with conventional prescription medications. Methods: The review delves into herbal supplements, clinical studies on natural remedies, aromatherapy, dietary influences, and lifestyle modifications in the context of migraine management in several databases. Results: The findings shed light on the potential of natural supplements as complementary or alternative approaches to traditional migraine therapies, offering insights into a holistic and personalized treatment paradigm for migraine sufferers. Conclusions: Natural supplements have gained attention as potential treatments for migraine relief, often perceived as safer alternatives to conventional medications.
AIM- The objective of the systematic review is to evaluate the incidence of postoperative pain after single-visit and multiple-visit root canal therapy. METHODS- Published research indexed in PubMed or Scopus or Cochrane or DOAJ or Web of Science evaluating the frequency percentage of postoperative aching after one and several root canal therapy appointments through randomized controlled trials or prospectively were included. RESULT- Most surveys utilized VAS (Visual Analogue Scale) to estimate the degree of pain among the participants. The majority of the studies (n-8) showed no difference between postoperative pain during single-sitting endodontic treatment or multiple-sitting endodontic treatment. On the contrary, several studies (n-6) also revealed that post-obturation pain in a single-appointment root canal therapy is less compared to multi-visit root canal therapy. The current research results give insight into the incidence of postoperative endodontic pain among the study participants undergoing root canal treatment through single or multiple visit appointments. CONCLUSION- The lack of consistency between studies is due to the different ways in which pain intensity is measured and differences in treatment methods, patient selection and treatment outcomes.
Journal of Taibah University for Science · vol. 19 (1)
A novel exopolysaccharide (EPS-R1) from the Red Sea bacterium Bacillus tequilensis MYG163 was isolated and characterized. The strain produced 6.33 g/l of EPS-R1, which was identified as a sulfated heteropolysaccharide containing uronic acid, N-acetyl glucose amine, and various monosaccharides. EPS-R1 showed strong antioxidant properties (>80% in DPPH and ABTS assays) and anti-inflammatory effects on COX-1 (IC50 = 25.74 µg/mL) and COX-2 (IC50 = 48.57 µg/mL). While safe for normal cells, it demonstrated cytotoxicity against colon (IC50 = 203.25 µg/mL) and pancreatic cancer cells (IC50 = 122.99 µg/mL). The compound effectively inhibited Candida albicans (MIC = 15.62 µg/mL) and showed superior antibacterial activity compared to gentamicin against Enterococcus faecalis (33 mm vs. 30 mm) and Klebsiella pneumoniae (42 mm vs. 17 mm). It significantly reduced bacterial biofilm formation (86-88% inhibition at 75% MBC) and Candida biofilms (60-90% reduction). These diverse bioactivities suggest EPS-R1's potential as a therapeutic agent.
Background: Severity of illness assessment tools are utilized to triage critically-ill patients and provide a valuable inputs to the healthcare provider to decide the type and intensity of treatment or interventions. Objective: The aim of this study was to evaluate the discriminatory capabilities of Acute Physiology And Chronic Health Evaluation II (APACHE II) score in the prediction of Intensive care units (ICUs) mortality among patients with sepsis admitted to the ICU. Methods: Records of patients with sepsis admitted to ICUs were retrospectively reviewed. Discriminatory performance of APACHE II score was assessed by using the receiver operating characteristic's (ROC's) area under the curve (AUC). Results: The mean±SD of APACHE II score was 27.1±8.4. APACHE II score demonstrated a very good discriminatory performance with an accuracy rate of 75% and an AUC-ROC 0.80 (95%CI: 0.74 - 0.85) at an optimal cutoff of 26. APACHE II score was found to be correlated with ICU mortality with a correlation coefficient of (0.52). ICU mortality was significantly higher in patients with APACHE II score ≥26. Conclusion: This study revealed that the discriminatory performance of APACHE II score in predicting ICU mortality in patient with sepsis was very good. These findings can have potential clinical implications in the identification and management of patients with sepsis admitted to the ICU.
APACHE II scoresepsisICU mortalitymortality prediction
AIM: To evaluate the efficacy and outcomes of integrative technologies employed in nursing-led interventions for the management of diabetes. BACKGROUND: With the global rise in diabetes prevalence, there is growing interest in digital health solutions to improve disease self-management. Nurses are increasingly leveraging technologies, such as mobile applications, wearable devices, and telehealth platforms, to support individuals with diabetes. However, the effectiveness and implementation outcomes of such nursing-led digital interventions remain variably reported in the literature. METHODS: A systematic review was conducted following PRISMA 2020 guidelines. Comprehensive five database searches (PubMed, CINAHL, Scopus, Web of Science, and Embase) identified randomized controlled trials (RCTs) from 2013 to 2024. Studies were included if they involved nurse-led interventions incorporating digital technologies for diabetes management. Data were synthesized using narrative and thematic analysis. Risk of bias was assessed using the RoB 2 tool. RESULTS: Thirteen RCTs involving diverse technologies demonstrated improvements in glycemic control (HbA1c reduction), self-management behaviors, and quality of life. Interventions incorporating personalized coaching, regular follow-up, and patient-centered feedback were particularly effective. Most studies were rated as low risk of bias, though some showed concerns regarding reporting practices and intervention fidelity. CONCLUSION: Nursing-led digital health interventions can significantly enhance diabetes care outcomes. Their success is contingent upon sustained patient engagement, nurse training, and organizational support. Broader implementation requires addressing digital literacy and system-level integration challenges. IMPLICATIONS FOR PRACTICE: Nurse-led technologies should be embedded in care models to support scalable, personalized, and effective diabetes self-management across diverse settings. CLINICAL TRIAL NUMBER: Not applicable.
diabetes managementnurse-led interventiondigital health technologiesmobile health apps
Frontiers in Pharmacology · vol. 16 · 1525529-1525529
Introduction: Gentamicin (GM) is a frequently used aminoglycoside for managing serious illnesses; nonetheless, renal complications limit its use. Bee venom (BV) is a biological toxin that exhibits anti-inflammatory and antioxidant activities. This study was designed to explore the mitigating effect of BV remediation on GM induced renal injury. Methods: Twenty male rats were divided into four groups (five rats each), namely, control (saline subcutaneously); BV group (1 mg/kg S/C twice weekly for 1 month); GM group (100 mg/kg i. p. for 1 week); and GM-BV group (the same aforementioned dosages of GM and BV, with GM administered in the last week for 4 weeks). Results and discussion: BV mitigated the GM-inflicted kidney damage, as evidenced by a substantial improvement in the renal function and oxidative state. In addition, a downregulation in the expression of inflammatory biomarkers (Casp-1, IL-6, TNF-α, and NF-κB/P65/P50) and an upregulation of oxidative stress marker expression (NRF2) were noticed. BV upregulated the expression of aquaporins (AQPs) and renal water channel proteins (AQP1 and AQP2), which are useful for the early detection of renal injury. Additionally, BV exposure exerted a mitigating effect on the apoptotic cascade, as evidenced by the downregulation of cleaved Caspase-3 (Casp-3) and cytochrome c (Cyto c). BV administration also led to an improvement in RBC, WBC, and platelet counts, along with enhanced Hb levels. Interestingly, BV could protect against GM triggered nephrotoxicity.